BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 15283939)

  • 1. A comparison of the central effects of different progestins used in hormone replacement therapy.
    Cagnacci A; Arangino S; Baldassari F; Alessandrini C; Landi S; Volpe A
    Maturitas; 2004 Aug; 48(4):456-62. PubMed ID: 15283939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
    Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of postmenopausal hormone replacement therapy on body fat composition.
    Yüksel H; Odabasi AR; Demircan S; Köseoğlu K; Kizilkaya K; Onur E
    Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal and metabolic effects of transdermal estradiol/progestagen administration in postmenopausal women.
    Perrone G; Falaschi P; Capri O; Pastore R; Galoppi P; D'Urso R; Martocchia A; Anelli G; Zichella L
    Int J Fertil Menopausal Stud; 1994; 39(4):202-7. PubMed ID: 7951402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestins used in hormonal replacement therapy display different effects in coronary arteries from New Zealand white rabbits.
    Pedersen NG; Pedersen SH; Dalsgaard T; Lund CO; Nilas L; Ottesen B
    Maturitas; 2004 Dec; 49(4):304-14. PubMed ID: 15531126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
    Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC; Christodoulakos GE; Lambrinoudaki IV; Dalamanga A; Alexandrou AP; Bramis J; Bastounis E; Creatsas GC
    Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study.
    Taner MZ; Ozpolat E; Taskiran C; Onan MA; Gursel T; Karabulut E; Gursoy R; Himmetoglu O
    Maturitas; 2006 Feb; 53(3):267-73. PubMed ID: 15978753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight-obese younger postmenopausal women.
    Demir B; Ozturkoglu E; Solaroglu A; Baskan B; Kandemir O; Karabulut E; Haberal A
    Gynecol Endocrinol; 2008 Jun; 24(6):347-53. PubMed ID: 18584415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition.
    Yüksel H; Odabaşi AR; Demircan S; Karul A; Kozaci LD; Köseoğlu K; Kizilkaya K; Başak O
    Gynecol Endocrinol; 2006 Jul; 22(7):381-7. PubMed ID: 16864148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of progestins of human proliferative endometrium: an in vitro model of potential clinical relevance.
    Illouz S; Dales JP; Sferlazzo K; Garcia S; Carpentier-Meunier S; Boubli L; Lavaut MN; Charpin C
    Int J Mol Med; 2003 Oct; 12(4):517-23. PubMed ID: 12964029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on haemostasis of hormone replacement therapy with transdermal estradiol and oral sequential medroxyprogesterone acetate: a 1-year, double-blind, placebo-controlled study. The Writing Group for the Estradiol Clotting Factors Study.
    Thromb Haemost; 1996 Mar; 75(3):476-80. PubMed ID: 8701411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.
    Sendağ F; Terek MC; Karadadaş N; Bilgin O
    J Reprod Med; 2001 Nov; 46(11):962-8. PubMed ID: 11762152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of progestogen on lipids, lipoproteins and apolipoproteins during transdermal estrogen replacement therapy with and without medroxyprogesterone acetate.
    Castelo-Branco C; Casals E; Sanllehy C; Duran M; Fortuny A; Vanrell JA
    J Reprod Med; 1996 Nov; 41(11):833-8. PubMed ID: 8951134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasomotor hot flashes and heart rate variability: a placebo-controlled trial of postmenopausal hormone therapy.
    Lantto H; Haapalahti P; Tuomikoski P; Viitasalo M; Väänänen H; Sovijärvi AR; Ylikorkala O; Mikkola TS
    Menopause; 2012 Jan; 19(1):82-8. PubMed ID: 21934534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels.
    Gol M; Akan P; Dogan E; Karas C; Saygili U; Posaci C
    Maturitas; 2006 Feb; 53(3):252-9. PubMed ID: 15990257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
    Samsioe G; Dvorak V; Genazzani AR; Hamann B; Heikkinen J; Mueck AO; Suzin J; Kawakami FT; Ferreira A; Sun D; Arguinzoniz M
    Maturitas; 2007 Jun; 57(2):171-81. PubMed ID: 17317046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of progestins on bone density and bone metabolism in postmenopausal women: a randomized controlled trial.
    Liu JH; Muse KN
    Am J Obstet Gynecol; 2005 Apr; 192(4):1316-23; discussion 1323-4. PubMed ID: 15846228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.